Skip to site alert.
Skip to content
Showing 1 - 10 of 122 results.
A treatment that prevents an often-fatal disease in fetuses and newborns only reaches half of the pregnant women around the world who need it, Columbia researchers have found.
NIH is giving out funds to develop seven new testing technologies which could increase testing capacity around the U.S. Daniel Green, MD, was quoted in this article about the RADx program.
Minah KIm, PhD, is one of the four Columbia cancer researchers selected to share seed funding raised from Velocity, Columbia’s Ride to End Cancer.
They gave scientific presentations covering COVID-19 and non-COVID-19 basic science topics as well as their most current research.
Kedrion Biopharma, a leading international biopharmaceutical company, partners with Columbia University Irving Medical Center to accelerate the development of an anti-COVID IgG therapy.
A 4½-minute video featuring FPO executive and faculty leadership recapping how the medical center responded to COVID-19.
The National Blood Foundation has just announced Eldad Hod, M.D. as one of its two newest members of the NBF Hall of Fame.
Marie Smithgall, a pathology resident, is this year's Society of ’67 scholar.
Pathology faculty member Sarah Vossoughi has been recently awarded the Air Force Outstanding Unit Award by the Secretary of the United States Air Force.
Columbia fertility experts have developed a one-step saliva test for diagnosing COVID-19 that could expand access to testing.